Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

298.85 +12.58 (+4.39%)
Official Closing Price Updated: 4:10 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Nearly 66% Of Patients Respond To Eli Lilly's Mirikizumab In Ulcerative Colitis Study
Patients with moderately-to-severely active ulcerative colitis (UC) who took Eli Lilly And Co's (NYSE: LLY) mirikizumab achieved statistically superior clinical... 
Via Benzinga
Friday the 13th on the 18th
Today stock markets more or less panicked over the fear of war. 
Via Talk Markets
Beware Of Neutrals
Retail sales are up 3.9% while online sales are down for Jan. 
Via Talk Markets
ICER's Report Suggests Benefits Of Eli Lilly's Tirzepatide Not Better Than Other Diabetes Drugs
Institute for Clinical and Economic Review (ICER) casts doubts on Eli Lilly And Co’s (NYSE: LLY) tirzepatide, a type II diabetes candidate, about its usefulness to... 
Via Benzinga
Give peace a chance
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today. 
Via Talk Markets
Lilly's Covid Antibodies Drove A Big Beat, But Omicron Will Limit Sales
Eli Lilly reported $1.06 billion in fourth-quarter sales of its Covid antibodies. 
Via Investor's Business Daily
Lilly Unites With ImmunoGen In ADC Deal Worth Up To $1.7B
ImmunoGen Inc (NASDAQ: IMGN) has struck a multi-target license deal with Eli Lilly And Co (NYSE: LLY) to grant exclusive rights to research, develop, and... 
Via Benzinga
Market Briefing For Tuesday, Feb. 15
It's no secret that when inflation reaches the levels it is at now, the way out of it is to crush demand. This is the price for the Fed being 'behind the curve' all last year. 
Via Talk Markets
World Markets News For Monday
European markets were down over fear of Ukrainian battles. 
Via Talk Markets
AstraZeneca Stock Ranked No. 1 In Group; Recently Reported Record Sales, Strong Outlook
AstraZeneca reported record sales, and a bullish outlook. AstraZeneca stock is idling though amid market weakness. Setting up for run higher? 
Via Investor's Business Daily
Large Cap Biopharma- Well Positioned For Choppy Markets
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets. 
Via Talk Markets
A Lot To Like At Lilly
Eli Lilly, one of our highest-P/E portfolio holdings, is an exemplar of a richly valued growth stock that should easily sail inflationary waters. 
Via Talk Markets
JAK Inhibitors Come Under EMA Scrutiny On Safety Concerns: All You Need To Know
Following the FDA's issuance of a safety warning regarding JAK inhibitors, the safety committee of the European Medicines Agency initiated a review of these treatments,... 
Via Benzinga
Lilly's Antibody Receives FDA Emergency Use Nod For Mild-To-Moderate COVID-19
The FDA on Friday authorized Eli Lilly And Co's (NYSE: LLY) COVID-19 antibody drug for people aged 12 and older at risk of severe illness. The FDA authorized... 
Via Benzinga
Week In Review: US FDA Rejects Innovent/Lilly PD-1 NDA Based On China-Only Trial Subjects
A US FDA oncology advisory panel rejected the NDA submitted by Innovent and Lilly for their partnered anti-PD-1 antibody. Lilly tried to influence the panel by announcing it would offer the drug at a... 
Via Talk Markets
FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab
The FDA advisory committee voted against the full approval of Eli Lilly And Co's (NYSE: LLY) lung cancer treatment over concerns that the clinical trial was... 
Via Benzinga
Psoriasis and the winter months: How one patient found relief to enjoy the holiday season
(BPT) - Sponsored by Eli Lilly and Company 
Via Brandpoint
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-... 
Via Benzinga
Can Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes
Drug behemoth Pfizer was the first to launch a Covid antiviral pill — but a pack of small biotech stocks are already nipping at its heels. 
Via Investor's Business Daily
Preprint Suggests, Vir-GSK's COVID-19 Antibody Can Evade Omicron Sub-Variant
In January, amid the omicron surge, WHO's expert panel recommended GlaxoSmithKline Plc (NYSE 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Markets News for Tuesday
Oil stocks are up on huge gains. 
Via Talk Markets
Amgen's Q4 Sales Remain Flat As Its Biggest Product Flounders
Amgen Inc's (NASDAQ: AMGN) Q4 revenues incr 
Via Benzinga
A News Blizzard
Markets are still down despite very encouraging news in January when 467,00 new hires got jobs. 
Via Talk Markets
Stock Market Rally Volatile; Google, Facebook, Amazon, Snap Are Earnings Movers: Weekly Review
The major indexes slashed weekly gains after Monday's follow-through day. 
Via Investor's Business Daily
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit. 
Via InvestorPlace
Regeneron Scores Quarterly Beat On Covid Cocktail — But Future Sales Are Shaky
Regeneron posted 104% sales growth, including $2.3 billion from REGEN-COV. 
Via Investor's Business Daily
Facebook FB plunges but Amazon AMZN surges: Earnings and Your Updated Price Levels
It seems like yesterday we were discussing the surge in Alphabet shares, and today we're focusing on big moves - currently in opposite directions - of Facebook and Amazon, all major market cap... 
Via Talk Markets
Weakened Tech Stocks
There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks. 
Via Talk Markets
Eli Lilly Q4 Earnings Beat Estimates On Higher Demand For Trulicity, COVID-19 Therapies; Reaffirms FY22 Guidance
Eli Lilly And Co (NYSE: LLY) has  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.